Zacks Investment Research upgraded shares of Applied DNA Sciences (APDND) from NEUTRAL to OUTPERFORM on November 14, 2014, with a target price of $12.00.
We are optimistic about the Company's unique technology and two principle anti-counterfeiting and product authentication solutions: SigNature DNA and fiberTyping, which can be used in numerous industries. With an ever booming anti-counterfeiting business worldwide, along with its unique technology and broad range of product offering, the Company is well positioned to grow in the coming years. APDN reported record revenue for fiscal 3Q14 and first nine months of fiscal 2014. We expect to see further growth of revenue in fiscal 4Q14 and beyond.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on Applied DNA Sciences (APDND),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment